Adial Pharmaceuticals (ADIL)

• Market cap: $7.79M
• 1 day: 1.86%
• 5 days: -0.92%
• 1 month: 0.91%
• 3 months: -24.76%
• 6 months: -48.3%
• Year to date: -66.35%
• 1 year: -64.17%
• 5 years: -99.18%
• 10 years: -99.65%
• Sector: Healthcare
• Industry: Biotechnology

About: Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.

Employees: 7